Capecitabine

NDC 62756-238 · Sun Pharmaceutical Industries, Inc.

Generic nameCapecitabine

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)CAPECITABINE

Strength150 mg/1

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

62756-238-18 — 1000 TABLET, FILM COATED in 1 BOTTLE (62756-238-18)

62756-238-86 — 60 TABLET, FILM COATED in 1 BOTTLE (62756-238-86)

62756-238-88 — 100 TABLET, FILM COATED in 1 BOTTLE (62756-238-88)

FDA lists these products with the same active ingredient.

31722-774 — capecitabine, 31722-775 — capecitabine, 51407-639 — Capecitabine, 51407-640 — Capecitabine, 55111-496 — capecitabine, 55111-497 — capecitabine, 59651-204 — Capecitabine, 59651-205 — Capecitabine, 60687-149 — Capecitabine, 61269-475 — capecitabine, 62756-239 — Capecitabine, 67877-458 — Capecitabine, 67877-459 — Capecitabine, 68001-487 — CAPECITABINE, 68001-488 — CAPECITABINE, 68001-643 — Capecitabine, 68001-644 — Capecitabine, 69097-948 — Capecitabine, 69097-949 — Capecitabine, 70756-815 — Capecitabine, +15 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.